Chunghwa Telecom
CHT
45.78
-0.30
-0.65%
Chunghwa Telecom
US · CHT
#599 by market cap
Listed 2003
45.78
-0.30
-0.65%
Live - 5344 symbols - heartbeat 53s ago
· 2026-10-07 19:54
After-hours
45.78
0.00%
- Market cap
- 35.51B
- P/E (TTM)i
- 29.33
- P/Bi
- 2.95
- EPSi
- 1.56
- Div yieldi
- 0.00%
- 52W posi
- 93%
Reader sentiment
Are you bullish or bearish on CHT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.38, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.67% YoY
Margins
- Gross margin
- 36.47%
- Operating margin
- 20.73%
- Net margin
- 16.49%
Key ratios & quality
- Enterprise valuei
- 7.94B
- PEG ratioi
- 13.92
- Altman Z-Scorei
- 1.38
PEG uses trailing P/E against the 3-year net income growth rate (2.11%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 215.48B | 207.52B | 207.61B | 210.48B | 216.74B | 223.20B | 229.97B | 236.11B |
| Gross profit | 75.94B | 71.36B | 70.36B | 74.33B | 78.99B | 79.73B | 81.99B | 85.61B |
| Selling & admin expenses | 27.76B | 26.98B | 25.92B | 26.24B | 29.40B | 30.40B | 32.28B | 33.74B |
| Research & development | 3.73B | 3.94B | 3.85B | 3.69B | 3.77B | 3.89B | 4.17B | 4.36B |
| Operating profit | 43.53B | 40.77B | 40.77B | 45.30B | 46.73B | 46.99B | 46.75B | 48.66B |
| Pretax profit | 44.99B | 41.87B | 42.83B | 46.07B | 47.20B | 47.01B | 47.84B | 50.27B |
| Tax | 6.41B | 7.95B | 8.12B | 9.02B | 9.34B | 8.95B | 9.33B | 9.78B |
| Net profit | 38.58B | 33.92B | 34.70B | 37.05B | 37.87B | 38.06B | 38.51B | 40.49B |
| Basic EPS | 48 | 43 | 43 | 46 | 47 | 48 | 48 | 50 |
| Diluted EPS | 48.30 | 42.40 | 43.00 | 45.90 | 46.80 | 47.60 | 47.80 | 49.80 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 55.81B | 56.73B | 57.92B | 65.65B | 59.99B | 61.36B |
| Gross profit | 21.23B | 21.44B | 21.19B | 21.75B | 22.43B | 22.66B |
| Selling & admin expenses | 7.93B | 8.17B | 8.16B | 9.51B | 8.40B | 8.63B |
| Research & development | 1.03B | 1.10B | 1.10B | 1.13B | 1.11B | 1.14B |
| Operating profit | 12.52B | 12.54B | 12.10B | 11.50B | 13.10B | 13.26B |
| Pretax profit | 12.70B | 13.13B | 12.26B | 12.18B | 13.18B | 13.95B |
| Tax | 2.50B | 2.53B | 2.40B | 2.34B | 2.57B | 2.69B |
| Net profit | 10.20B | 10.60B | 9.85B | 9.84B | 10.61B | 11.27B |
| Basic EPS | 13 | 13 | 12 | 12 | 13 | 14 |
| Diluted EPS | 12.60 | 13.10 | 12.20 | 12.00 | 13.00 | 13.70 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 91.69B | 94.07B | 81.80B | 91.02B | 101.90B | 103.20B | 112.97B | 117.37B |
| Cash & ST investments | 37.15B | 41.55B | 36.55B | 44.08B | 53.00B | 53.28B | 58.93B | 58.59B |
| Inventory | 17.54B | 19.68B | 14.57B | 14.16B | 14.70B | 13.75B | 14.09B | 15.32B |
| Total assets | 467.06B | 477.13B | 506.18B | 512.88B | 523.00B | 523.74B | 534.30B | 535.68B |
| Total current liabilities | 63.22B | 66.14B | 73.22B | 66.23B | 67.74B | 67.75B | 82.00B | 81.07B |
| Short-term debt | 100.00M | 3.38B | 12.05B | 3.28B | 4.06B | 5.69B | 12.58B | 6.13B |
| Long-term debt | 1.60B | 1.60B | 19.98B | 28.58B | 32.08B | 30.48B | 23.32B | 24.89B |
| Total liabilities | 82,527,000,000.00 | 92,856,000,000.00 | 118,907,000,000.00 | 123,745,000,000.00 | 131,467,000,000.00 | 131,022,000,000.00 | 138,491,000,000.00 | 137,209,000,000.00 |
| Total equity | 384.53B | 384.27B | 387.27B | 389.13B | 391.53B | 392.72B | 395.81B | 398.47B |
| Retained earnings | 146.88B | 146.23B | 147.82B | 150.41B | 151.93B | 152.53B | 154.61B | 154.61B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 118.62B | 128.70B | 99.79B | 117.37B | 134.46B | 143.77B |
| Cash & ST investments | 65.01B | 73.95B | 40.11B | 58.59B | 66.74B | 79.57B |
| Inventory | 13.82B | 14.20B | 15.89B | 15.32B | 17.53B | 20.26B |
| Total assets | 537.23B | 544.48B | 513.10B | 535.68B | 547.81B | 553.63B |
| Total current liabilities | 72.88B | 111.63B | 66.52B | 81.07B | 81.80B | 117.47B |
| Short-term debt | 13.07B | 14.99B | 6.47B | 6.13B | 9.89B | 8.39B |
| Long-term debt | 23.32B | 21.42B | 24.89B | 24.89B | 23.29B | 23.03B |
| Total liabilities | 128,954,737,000.00 | 164,861,133,000.00 | 122,665,684,000.00 | 137,209,000,000.00 | 136,380,954,000.00 | 171,548,938,000.00 |
| Total equity | 408.28B | 379.62B | 390.43B | 398.47B | 411.43B | 382.08B |
| Retained earnings | 145.00B | 116.38B | 125.82B | 154.61B | 145.32B | 115.63B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 66.37B | 72.43B | 74.46B | 74.86B | 75.95B | 79.24B | 74.56B | 77.45B |
| Depreciation & amortization | 31.87B | 35.18B | 36.37B | 38.40B | 39.43B | 39.62B | 39.66B | 40.22B |
| Free cash flow | 37.32B | 47.90B | 3.34B | 39.27B | 42.52B | 50.25B | 43.58B | 49.60B |
| Dividends paid | -37.21B | -34.75B | -32.78B | -33.40B | -35.75B | -36.91B | -36.48B | -38.79B |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 27.65B | 34.05B | 30.42B | 39.78B | 50.19B | 36.26B | 33.82B | 36.94B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 12.95B | 16.33B | 16.17B | 31.99B | 11.10B | 20.64B |
| Depreciation & amortization | 10.01B | 10.03B | 10.01B | 10.16B | 10.20B | 10.25B |
| Free cash flow | 7.17B | 9.38B | 10.03B | 23.02B | 6.24B | 15.21B |
| Dividends paid | -- | -- | -- | 232.00K | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 29.05B | 35.03B | 23.53B | 36.94B | 35.23B | 42.22B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 10.21 | 8.80 | 8.91 | 9.45 | 9.61 | 9.73 | 9.75 | 10.09 |
| ROA %i | 8.18 | 6.98 | 6.80 | 6.99 | 7.02 | 7.06 | 7.03 | 7.23 |
| ROIC %i | 10.12 | 8.62 | 8.37 | 8.60 | 8.67 | 8.67 | 8.67 | 9.02 |
| 5-year avg ROE %i | 10.81 | 10.52 | 9.98 | 9.64 | 9.40 | 9.30 | 9.49 | 9.73 |
| EBIT margin %i | 20.89 | 20.23 | 20.73 | 22.10 | 22.01 | 21.37 | 21.08 | 21.57 |
| FCF / sales %i | 17.32 | 23.08 | 1.61 | 18.75 | 19.71 | 19.68 | 21.99 | 21.13 |
| Current ratioi | 1.45 | 1.42 | 1.12 | 1.37 | 1.50 | 1.52 | 1.38 | 1.45 |
| Quick ratioi | 1.14 | 1.09 | 0.88 | 1.12 | 1.25 | 1.27 | 1.15 | 1.19 |
| Debt / assetsi | 0.36 | 2.40 | 7.56 | 7.59 | 8.31 | 8.33 | 8.09 | 7.10 |
| LT debt / equityi | 0.43 | 2.16 | 6.96 | 9.44 | 10.40 | 9.98 | 8.01 | 8.30 |
| Interest coveragei | 2,500.22 | 403.57 | 208.89 | 212.32 | 180.48 | 148.36 | 142.12 | 136.86 |
| Revenue CAGR (3Y) %i | -2.40 | -3.40 | -3.04 | -0.94 | 1.33 | 2.22 | 2.96 | 2.86 |
| Net income CAGR (3Y) %i | -3.69 | -6.64 | -5.01 | -1.75 | 3.34 | 3.41 | 1.45 | 2.11 |
| FCF CAGR (3Y) %i | -2.98 | 5.19 | -53.28 | 1.71 | -3.89 | 146.87 | 3.53 | 5.27 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 9.54 | 10.37 | 10.22 | 10.09 | 9.86 | 10.77 |
| ROA %i | 7.06 | 7.02 | 7.51 | 7.23 | 7.19 | 7.19 |
| ROIC %i | 8.50 | 9.16 | 9.11 | 9.02 | 8.82 | 9.59 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 21.32 | 21.43 | 21.55 | 21.57 | 21.39 | 21.33 |
| FCF / sales %i | 21.24 | 20.96 | 18.91 | 21.13 | 20.37 | 22.38 |
| Current ratioi | 1.63 | 1.15 | 1.50 | 1.45 | 1.64 | 1.22 |
| Quick ratioi | 1.33 | 0.95 | 1.14 | 1.19 | 1.31 | 0.99 |
| Debt / assetsi | 8.16 | 8.02 | 7.52 | 7.10 | 7.26 | 6.90 |
| LT debt / equityi | 7.78 | 7.81 | 8.53 | 8.30 | 7.54 | 8.13 |
| Interest coveragei | 141.70 | 140.34 | 140.41 | 136.86 | 133.45 | 131.12 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Consumer Business is the largest reported line at 59.39% of revenue, across 5 reported segments.
- Enterprise Business follows at 32.47%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Consumer Business59.39%
Enterprise Business32.47%
International Business6.79%
Others3.46%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.